Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
IRulya Therapeutics, Inc., formerly Quince Therapeutics, Inc., is a clinical-stage biopharmaceutical company. It is developing a novel disease-modifying therapeutic to address the unmet medical need associated with pulmonary disorders. Its lead asset, LAM-001, a proprietary investigational inhaled dry powder formulation of rapamycin whose differentiated characteristics may permit treatment of pulmonary conditions associated with dysfunctional mammalian target of rapamycin activity. It is evaluating the use of LAM-001 as a treatment for patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and for patients with bronchiolitis obliterans syndrome post lung transplant (BOS). It also completed a Phase 2a trial, which enrolled patients with pulmonary arterial hypertension as well as patients with PH-ILD and sarcoidosis associated pulmonary hypertension (SAPH) where it achieved clinically relevant improvement across multiple endpoints, and others.
Find out what a historical investment in IRulya Therapeutics Inc would be worth today using our IRLA stock calculator.
Buying IRLA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in IRulya Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in IRLA
What is the ticker symbol of IRulya Therapeutics Inc?
The ticker symbol for IRulya Therapeutics Inc is IRLA.
How much is one share of IRLA?
One share of IRLA is valued at $40.07 as of 20 November 2026.
What is the market capitalisation of IRulya Therapeutics Inc IRLA?
As of 20 November 2026 IRulya Therapeutics Inc has a market cap of $440.06M.
What is the 52-week high for IRulya Therapeutics Inc stock?
The IRulya Therapeutics Inc 52-week high stock price is $909.98.
What is the 52-week low for IRulya Therapeutics Inc stock?
The IRulya Therapeutics Inc 52-week low stock price is $15.10.
Can I buy IRLA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IRLA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IRLA on Stake
Buy IRLA from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of IRLA from only US$10 with fractional shares